Figure 2. The changes in the Tg levels (A) and NLR (B) in the radioactive iodine-refractory differentiated thyroid carcinoma patients who were administered sorafenib. PR: Partial response; SD: stable disease; PD: progressive disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.